RNAZ TRANSCODE THERAPEUTICS INC Investor Conferences 8-K Filing 2023 - Annual Meeting of Stockholders TransCode Therapeutics held its 2023 Annual Meeting of Stockholders, where stockholders approved the election of directors, a reverse stock split proposal, an adjournment proposal, and the appointment of an independent registered public accounting firm.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC